KBC Group
CBST

KBC Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

KBC Group’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,362
Closed -$1.34M – 1489
2014
Q4 		$1.34M Buy
13,362
+620
+5% +$48.2K 0.02% 684
2014
Q3 		$845K Sell
12,742
-4,360
-25% -$286K 0.03% 578
2014
Q2 		$1.19M Sell
17,102
-449
-3% -$30.5K 0.01% 717
2014
Q1 		$1.28M Sell
17,551
-13,597
-44% -$1.01M 0.02% 599
2013
Q4 		$2.15M Buy
31,148
+3,963
+15% +$257K 0.03% 502
2013
Q3 		$1.73M Buy
27,185
+608
+2% +$36.8K 0.03% 547
2013
Q2 		$1.28M Buy
+26,577
New +$1.31M 0.02% 608

KBC Group's CBST Position: Q1 2015 in Review

KBC Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 13,362 shares — an estimated $1.34M sold.

KBC Group first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $2.15M in Q4 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • KBC Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • KBC Group sold 13,362 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.34M.
  • KBC Group first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • KBC Group's CUBIST PHARMACEUTICALS INC position peaked at $2.15M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on KBC Group's 13F filing for Q1 2015, filed 30 Apr 2015.